RE:Interesting Developmentsfamar wrote: Great surprize to me,,,,,I don't mind Paul saying I told you so and punish us with some more exciting NRs. But a 2.00/device by 50-mil would be quite substantial.
Pristine Surgical anticipates expanding into a broader portfolio of rigid and flexible endoscopes, totaling 125 million procedures worldwide each year.
GLTA...fmb
This stock appeared on my radar because of its volume and % increase. I own no shares at this time. Why did it go up all of a sudden? Was it because of the "125 million procedures" reference??? As a fresh observer, here's what I've noticed:
- Volume and price rose slightly before this latest NR, after months of silence, which suggests insider trading... Not good
- This appears to not be the first time that NXO edged "closer to commercialization", yet there's not a single product on sale after decades and millions of $. NXO even warns:
"There can be no assurances of commercial success or profitable operations."
I've never seen a commercially "edging" company noting both millions in potential sales and none at the same time. This seems deceptive.
- Given that NXO would've likely boasted about even a single sale of its product, it seems certain that Pristine sold no units since the unveiling in April:
"Pristine Surgical received its FDA 510(k) clearance for Summit™, the world's first 4K single-use surgical arthroscope in January 2023, completed its first in human procedure in April 2023 and began its limited market release in the United States shortly thereafter.
Strength of revenue from NexOptic's perspective will be predicated upon the number of surgical centers that incorporate Summit into their surgical procedures."
- Given that there were no sales during the past 5 months, the following is odd:
"Pristine Surgical anticipates expanding into a broader portfolio of rigid and flexible endoscopes, totaling 125 million procedures worldwide each year."
These "limited release" and "anticipated expansion" claims, after having achieved nothing, leads me to believe that this latest NR and bump in price are a ploy to raise money shortly. The goal is to create some kind of buzz. Jon Brown added some extra fluff to reinforce the message of "potential":
"According to Grand View Research, the global artificial intelligence market was valued at US$136.55 billion in 2022 with a projected CAGR of 37.3 per cent to nearly US$2 trillion from 2023 to 2030."
None of this has anything to do with NXO or Pristine. Rather than legitimate, justified, interest, the tactic used appears to be to inject a few thousand $ into the market to dupe potential PP suckers into investing a couple of millions for "general operating purposes".